MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Engagement of the Black and African American Community in Parkinson’s Genetic Research

    E. Stevens, A. Kumeh, S. Sauveur, D. Oguoma-Richards, R. Huckabee, A. Huckabee, D. Coley, B. Coley, M. Fitts, E. Lewis, L. Seghetti, T. Best, K. Gamble, K. Williams, L. Wilson, R. Joseph, H. Shah, C. Gallagher, C. Evers, J. Beck, A. Naito, C. Branson (New York, USA)

    Objective: Increase racial diversity in Parkinson’s disease (PD) genetic research by engaging Black and African American people living with PD Background: Advancements in understanding the…
  • 2024 International Congress

    Clinical and genetic characteristics of PLA2G6-parkinsonism in southwest of China and a review of heterogeneity of phenotype and genotype between Asian and Caucasian patients

    YF. Cheng, HF. Shang (Chengdu, China)

    Objective: Objective: To summarize clinical characteristics, imaging features and genetic data of PLA2G6 mutant patients in southwest of China, and to investigate the heterogeneity between Asian and…
  • 2024 International Congress

    Clinical Features of dj1 Gene Mutation Causing Parkinson’s Disease from Single Institution

    H. Alhodaif, Y. Alkhodair, A. Aldakheel, S. Alqahtani, S. Boholegah (Riyadh, Saudi Arabia)

    Objective: Describe a detailed clinical and genetic evaluation of patients with Parkinson's disease secondary to DJ1 gene mutation Background: Inherited Parkinson's disease (PD) represents 5-10%…
  • 2024 International Congress

    Wilson’s Disease : A Senegalese Series of Seven Patients Followed at Pikine National Hospital Centre (Dakar-Senegal)

    M. Fall, A. Diop, J. Kahwagi (Dakar, Senegal)

    Objective: The aim of this study is to describe the epidemiological, diagnostic, therapeutic and evolutionary characteristics of Wilson's disease and to highlight the diagnostic and…
  • 2024 International Congress

    Prevalence of immune-mediated diseases in long-term chelator therapy in Wilson’s Disease

    C. Guedes Vaz, H. Pessegueiro, J. Castro Ferreira, J. Gandara, V. Dionísio Lopes, E. Silva, S. Ferreira, C. Pereira, D. Valadares, L. Maia, J. Presa, A. Pinto, A. Costa, C. Rolanda, C. Agostinho, I. Gonçalves, P. Peixoto, R. Costa, S. Lopes, M. Magalhães (Porto, Portugal)

    Objective: To determine the prevalence of concurrent immune-mediated diseases during copper chelation therapy in Wilson’s disease (WD). Background: Wilson’s disease is a neurometabolic autosomal recessive…
  • 2024 International Congress

    Adult-onset Niemann-Pick C in India: phenotype and genotype

    S. Bhowmick, J. Ganguly, D. Garg, V. Holla, P. Wadia, H. Shah, P. Shah (Vadodara, India)

    Objective: This study was aimed to describe the clinical, radiological, and molecular profile of adults affected by NPC. Background: Adult-onset Niemann-Pick C (NPC) is a…
  • 2024 International Congress

    Clinical, Neurophysiological, and Biological Insights into Levodopa-Induced Dyskinesias

    B. Angeloni, A T. Cimmino, R. Di Iorio, P. Calabresi, G. Di Lazzaro (Rome, Italy)

    Objective: The aim of this study was to determine the clinical, neurophysiological and biological features of Parkinson's Disease (PD) patients with L-Dopa-induced dyskinesias (LIDs). Background:…
  • 2024 International Congress

    Quantification of an Upper Limb Rigidity Network in Parkinson Disease

    M. Bange, H. Ding, N. Koirala, M. Reich, C. Ip, B. Nasseroleslami, G. Deuschl, J. Volkmann, M. Muthuraman (Augsburg, Germany)

    Objective: To explore the cortico-subcortical network related to rigidity. Background: Rigidity of the upper limb is one of the cardinal symptoms in Parkinson’s disease (PD),…
  • 2024 International Congress

    V-ATPase subunit V1G1 overexpression conferred the mice neuroprotection during MPTP exposure

    YIM. Wang, Y. Li, Y. Xia, L. Kou, T. Wang (武汉市, China)

    Objective: Elucidating the role of lysosomal dysfunction due to altered stability and expression levels of V-type proton ATPase subunit G (V1G1) in the degradation and…
  • 2024 International Congress

    Determining Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical Data

    C. Venuto, K. Herbst, K. Kieburtz (Rochester, USA)

    Objective: To develop models that determine likeliness of positive detection of pathologic alpha-synuclein (asyn) in cerebrospinal fluid (CSF) as measured by seed amplification assay (SAA)…
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley